Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:35 AM
Ignite Modification Date:
2025-12-25 @ 4:35 AM
NCT ID:
NCT07191418
Eligibility Criteria:
Inclusion Criteria:
* Individuals with newly diagnosed pancreatic cancer in the head of the pancreas causing compression on the bile duct.
* Metastatic stage to the liver
* Histologically or cytologically confirmed mPDAC.
* Cancer burden limited to maximum 5 metastases in the liver, each of them maximum 1 cm in the larger diameter.
* Patients must be under palliative chemotherapy treatment.
* Cancer should be radiologically measurable (in an area not previously irradiated).
* WHO performance status 0-2.
* Age 18-85 years.
Exclusion Criteria:
* Intellectual disability, unwillingness or language difficulties
* which hinders the ability to give informed consent.
* Ongoing extensive immunosuppression and/or severe leuko- or
* thrombocytopenia.
* Ongoing acute cholangitis.
* Ongoing sepsis.
* Acute kidney failure.
* Uncompensated heart failure or unstable coronary insufficiency
* (symptomatic/uncompensated).
* Pregnancy or breastfeeding.
* Any metastases outside the liver.
* Cardiac pacemakers/cardioverter defibrillators.
* Severe coagulopathy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT07191418
Study Brief:
Protocol Section:
NCT07191418